Repligen and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purification of pH Sensitive AntibodiesGlobeNewsWire • 09/09/21
Repligen (RGEN) Up 16.5% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 08/26/21
After Golden Cross, Repligen (RGEN)'s Technical Outlook is BrightZacks Investment Research • 08/03/21
Repligen Corp, Inc. (RGEN) CEO Anthony Hunt on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 07/27/21
Repligen Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Financial GuidanceGlobeNewsWire • 07/27/21
Repligen (RGEN) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 07/20/21